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ABSTRACT: Spatial and temporal expression and
regulation of the antioxidant enzymes, glutathione
peroxidase (GSH-Px), glutathione disulfide reductase
(GSSG-Rd) may be important in determining cell-
specific susceptibility to embryotoxicants. Creation
of tissue-specific ontogenies for antioxidant enzyme
activities during development is an important first
step in understanding regulatory relationships. Early
organogenesis-stage embryos were grouped according
to the somite number (GD 9–13), and fetuses were eval-
uated by gestational day (GD 14–21). GSH-Px activities
in the visceral yolk sac (VYS) increased on consecu-
tive days from GD 9 to GD 13, representing a 5.7-fold
increase during this period of development. GSH-Px
activities in VYS decreased after GD 13, ultimately con-
stituting a 37% decrease at GD 21. Head, heart, and
trunk specific activities generally increased from GD
9 to GD 13 albeit not to the same magnitude as de-
tected in the VYS. GSSG-Rd activities showed sub-
stantial increases in the VYS from GD 9 to GD 13,
6.3-fold and decreased thereafter to 50% by GD 21. The
greatest changes in enzyme activities were noted in the
period between GD 10 and GD 11, where the embryo
establishes an active cardiovascular system and begins
to convert to aerobic metabolism. Generally, from GD
14–21, embryonic organ GSH-Px and GSSG-Rd activi-
ties either remained constant or increased as gestation
progressed. These studies suggest the importance of
the VYS in dealing with ROS and protecting the em-
bryo. Furthermore, understanding the consequences of
lower antioxidant activities during organogenesis may
help to pinpoint periods of teratogenic susceptibility to
xenobiotics and increased oxygen. C© 2001 John Wiley
& Sons, Inc. J Biochem Mol Toxicol 15:197–206, 2001
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INTRODUCTION
Early experimental evidence indicates that em-
bryos are most susceptible to toxic insult during the
period of organogenesis [1]. The mammalian embryo
is metabolically active, and as gestation proceeds, the
utilization of oxygen increases when aerobic metabolic
processes mature to support cellular function [2]. Dur-
ing organogenesis, oxygen requirements for optimal
embryonic growth in vitro are shown to be stage spe-
cific, increasing from 5% O2 on gestational day (GD) 9 to
95% on GD 11. Within this interval the pathways of en-
ergy metabolism shifts from predominantly anaerobic
glycolysis to aerobic glycolysis, active Krebs cycle func-
tion, and oxidative phosphorylation [3–6]. Since these
latter processes require O2, embryonic growth is de-
pendent on significantly increasing O2 concentrations
[2,7–10]. As embryonic requirements for O2 increases,
the probability of reactive oxygen species (ROS) forma-
tion also increases, and the cell must adapt, removing
ROS and preventing cell damage and death.
Excessive generation of ROS can initiate changes
that are detrimental for the cell, namely lipid perox-
idation, DNA breakage, protein degradation, and en-
zyme deactivation [11]. However, a finite amount of
ROS is generated during the normal physiological con-
ditions that exist during organogenesis, and its regula-
tion is important for maintaining viability and normal
cell function. The generation of ROS is initiated by a
single-election reduction of O2 to yield intermediates,
which transfer one electron to O2 with the resulting
formation of superoxide anion radical (O−2 ). Super-
oxide anion radical undergoes dismutation to hydro-
gen peroxide (H2O2) by superoxide dismutase (SOD).
Hydrogen peroxide can then be detoxified to water but
under conditions where protective measures are over-
whelmed, H2O2 will be converted to the highly reac-
tive hydroxyl radical (HO•) via the transition metal
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dependent Harber–Weiss reaction [11]. If not removed,
the hydroxyl radical can produce structural and func-
tional damage that eventually leads to cell death.
Glutathione (GSH) is the most abundant endoge-
nous intracellular thiol (0.2–10 mM), found in most
mammalian and many prokaryotic cells. It is well
known for its cellular protective roles against ROS and
free radicals by acting as a radical scavenger and intra-
cellular antioxidant [12,13]. Glutathione is also known
to be an important regulatory element because of its role
in maintaining intracellular redox status which, in turn,
has been shown to regulate cellular functions including
enzyme activities, signal transduction, macromolecu-
lar synthesis, cell proliferation, and maintenance of
membrane integrity [13,14]. Since GSH serves in these
capacities in the cell, the regulation of GSH status is of
importance in protection against toxicity.
Enzyme pathways exist within the cell to combat
the hazardous effects of ROS by acting directly as an an-
tioxidant or regulating GSH status. Molecular oxygen
can be converted into ROS via several routes such as,
electron leakage in the mitochondria, cellular oxidases
(lipoxygenase, cyclooxygenase, xanthine oxidase, etc.),
and xenobiotics [11]. The anticonvulsant mephenytoin,
the alkylating cancer agent cyclophosphamide, and the
keratolytic agent isotretinoin are all known teratogens
which are capable of producing oxidative stress as a
result of increased production of free radical interme-
diates and/or subsequent ROS formation. Compounds
like paraquat, doxorubicin, and nitrobenzene, which
are also teratogens, are detrimental due to their ability
to redox cycle [15–20]. Although the superoxide anion
can spontaneously form hydrogen peroxide at physio-
logical pH, this reaction is rather slow. Superoxide dis-
mutase catalyzed detoxication of superoxide anion to
hydrogen peroxide is much more efficient in removing
ROS from the cell and is relatively independent of pH.
If not removed, hydrogen peroxide can readily cross
plasma membranes and can be effectively metabolized
by catalase or glutathione peroxidase (GSH-Px) with
GSH acting as a cofactor, resulting in glutathione disul-
phide (GSSG) and water [11].
H2O2 + 2GSH→ GSSG+ 2H2 O (1)
Moreover, GSH can interact with ROS independent
of GSH-Px, becoming oxidized to GSSG and reducing
ROS in the process [11].
2GSH+ 2R• → GSSG+ 2RH (2)
Whether formed spontaneously or from reactions in-
volving GSH-Px, GSSG can be recycled back to GSH
enzymatically via GSSG-Rd using NADPH as the
critical cofactor [11,12,21].
GSSG+NADPH+H+ → 2GSH+NADP+ (3)
Control of the GSH/GSSG cycle prevents drastic
changes in both GSH and GSSG concentrations and al-
lows for shorter periods of redox imbalance.
Recent advances in our understanding of molecular
regulation of gene expression and signal transduction
suggest an important role of GSH and redox status.
The developmental associations of antioxidant activi-
ties and redox status are, therefore, closely linked to cell
and tissue differentiation [1,22–24]. During differenti-
ation, cells become increasingly oxidized and changes
in antioxidant function include a drop in intracellular
GSH content and an increase in GSSG as GSH reacts
with ROS [25,26]. Given the major role of GSH in main-
taining cellular redox balance and the significance of
this balance during differentiation, proliferation, and
apoptosis, additional oxidative stress caused by chem-
ical exposure could pose a serious threat to the regula-
tion of normal growth and development, and further
diminish the capacity of tissues to biotransform xeno-
biotics [11].
Glutathione peroxidase (GSH-Px) and glutathione
disulfide reductase (GSSG-Rd) are directly involved in
the regulation of GSH and intracellular redox status.
Inherent spatial and temporal variations in GSH-Px
and GSSG-Rd specific activities may predispose certain
cells or tissues to oxidative damage, redox imbalance,
and misregulation of particular intracellular events
important during embryonic maturation. Changes in
redox status not only predispose the embryo to oxida-
tive stress but are also known to modulate changes in
gene expression [26,27 and reviewed in 28,29]. Such
differences may be useful in understanding cell and
species selectivity of various teratogens.
MATERIALS AND METHODS
Chemicals
Sodium azide, b-NADPH, glutathione, glutathione
disulfide, glutathione reductase (Type III: from Bakers
Yeast), hydrogen peroxide (H2O2), superoxide dismu-
tase (from Bovine), and epinephrine were all obtained
from the Sigma Chemical Company (St. Louis, Mo.).
All other chemicals and reagents were of purest grade
commercially available.
Animals and Tissue Preparation
Primagravida Sprague-Dawley rats were time-
mated and used in all experiments. Day 0 of gestation
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was designated the morning following copulation as
indicated by a sperm-positive vaginal smear. Animals
were obtained on gestation days 6–9 from the Repro-
ductive Science Program, Small Animal Core, Univer-
sity of Michigan, and maintained on a 12-h light/
12-h dark cycle until explantation on the designated
gestational day. Rats were allowed unrestricted access
to food and water.
Developmental stages were categorized by ranges
of somite numbers. Range one is somite number
0–12 which represent gestational days GD 9 through
GD 10. Range two includes somite numbers 13–20
(GD 10), and range three encompasses somite numbers
21–28 (GD 11). Range four includes embryos of 29 or
more somites, corresponding to GD 12. At each spe-
cific time point, conceptuses were carefully removed,
placed, and washed in warmed Hank’s Balanced Salt
Solution (HBSS; pH 7.4). One or two embryos and vis-
ceral yolk sacs (VYSs) were stored in microcentrifuge
tube containing an appropriate buffer. Heads, hearts,
and trunks were also dissected from the embryo and
placed in a separate tube. Samples were frozen and
stored at −70◦C until processed for enzyme assay.
For tissues removed at later stages of development,
fetuses were dissected free of the uterus and immedi-
ately decapitated on ice. One to two litters were sacri-
ficed at each time point of the study. The brain, heart,
liver, lung, and kidney were excised and washed with
cold HBSS, and then stored in test tubes with appropri-
ate buffers for enzyme assay. Placentae and VYSs were
carefully removed prior to collection of other samples,
snap-frozen, and stored at −70◦C until analysis.
Superoxide Dismutase Assay
Conceptuses collected in somite ranges one
through four were separated into embryos and VYS
and were placed in groups (as described earlier) of 2 in
200 mL of 50 mM Tris-HCl (pH 7.4). The frozen sam-
ples were thawed and sonicated before assay. The SOD
assay was performed as originally described by Sun
and Zigman [30]. The reaction mixture of 200 mM
sodium carbonate/EDTA and 0.3 mM epinephrine
(in 0.1 N HCl) were made fresh prior to each assay.
One hundred and fifty microliters of sodium carbon-
ate/EDTA and 20 mL sample or buffer (for blank) were
added to each cuvette and allowed to warm to 30◦C for
5 min. To activate the reaction, 30 mL epinephrine was
added to the final mixture in the dark. SOD activity was
determined spectrophotometrically with a Beckman
BU-650 spectrophotometer by measuring the formation
of adrenochrome at 320 nm at 30◦C for 10 min. SOD ac-
tivity was determined by the percent inhibition of the
control [30]. One unit of activity was defined as the
amount of enzyme producing a 50% inhibition of the
conversion of epinephrine to adrenochrome, measured
by change in absorbency. Therefore, higher numbers
correlate with less SOD activity as more homogenate is
needed to produce a 50% inhibition. Specific activities
were determined as units of activity per milligram pro-
tein. Protein was measured using the Bradford assay
[31].
Glutathione Peroxidase Assay
The GSH-Px assay was performed as origi-
nally described by Lawrence and Burk [32]. Samples
were put in 50 mM potassium phosphate (K2HPO4;
pH 7.0) buffer and were frozen in liquid nitrogen and
stored at −70◦C. At the time of assay, samples were
thawed at room temperature, homogenized by ultra-
sonic tissue disruption and placed on ice. A Beckman
BU-650 spectrophotometer was used for this spec-
trophotometric assay. Each cuvette contained 150 mL
of reaction mixture with 50 mM potassium phosphate
(K2HPO4; pH 7.0) solution, 1 mM EDTA, 1 mM NaN3,
2 mM NADPH, and 1 mM GSH. Six microliters of
GSSG-Rd (1 E.U./ml) was added at the last step of re-
action mixture. Blank cuvettes then received 50 mL of
K2HPO4 buffer while sample cuvettes received 50 mL of
sample. All reactions were gently mixed and incubated
at 30◦C for 4 min. To activate the reaction, 0.25 mM
H2O2 solution was added and mixed into each cuvette.
Absorbency was immediately determined at a fixed
wavelength of 340 nm for 4 min. The rate of NADPH
oxidation correlates with the oxidation of H2O2 by
GSH-Px. Specific activities were calculated by dividing
the rate of oxidation of NADPH (mmol/min) by the mil-
ligrams of protein (nmol NADPH oxidized/min/mg
protein). Protein was determined by the method of
Bradford [31]. Concentrations of NADPH oxidized are
calculated from the molar extinction coefficient (6.22×
103 M−1 cm−1). A dilution of the sample was performed
in order to obtain a linear enzymatic reaction. Each
reaction was carried out in duplicate.
Glutathione Reductase Assay
The GSSG-Rd activity was measured using
the method originally described by Carlberg and
Mannervik [33]. Samples were placed in 0.2 M K2H
PO4/2 mM EDTA (pH 7.0) buffer and frozen at −70◦C
until analysis. At the time of assay, samples were
thawed, homogenized by ultrasonic tissue disruption
at room temperature, and immediately placed on ice.
The reaction mixture consisted of 100 mL of 0.2 M
K2HPO4/EDTA (pH 7.0) solution, 10 mL of 2 mM
NADPH/Tris-HCl solution. All mixtures and solutions
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were prepared at room temperature. Blank cuvettes
then received 80 mL of deionized water while sample
cuvettes received 30 mL of deionized water and 50 mL
of sample. The reaction was initiated by adding and
mixing 20 mM GSSG to all the tubes with the final
volume of 200 mL. NADPH oxidation was followed
for 4 min and was recorded using a Beckman BU-650
spectrophotometer. The reduction of GSSG to GSH was
determined indirectly by the measurement of the con-
sumption of NADPH, as demonstrated by a decrease
in absorbance at 340 nm as a function of time. Specific
activities were calculated by dividing the rate of oxida-
tion of NADPH (mmol/min) by the milligrams of pro-
tein (nmol NADPH oxidized/min/mg protein). Protein
content was determined by the method of Bradford [31].
Statistical Analysis
Fetuses were collected from 8–12 pregnant dams
for each time point (GD 9–21). A total of 15–20 em-
bryos/fetuses/tissues (n) isolated from different litters
were used for each individual assay. As no more than
2 embryos/fetuses/tissues from any one litter were used
for a single assay, each embryo/fetus/tissue represents
each individual litter while lessening the number of
animals needed for this study. In addition, each em-
bryo/fetus/tissue was assayed in duplicate to a reliable
level of reproducibility. For differences between tissues,
a one way ANOVA followed by a Tukey’s Studentized
Range (HSD) was used, where p values<0.05 were con-
sidered a demonstration of a significant difference.
RESULTS
Enzyme Activities: Early Organogenesis
(GD 9–13)
Glutathione Peroxidase
Embryonic GSH-Px activity did not change signif-
icantly during the period of development from GD 9
to GD 13 (Figure 1). VYS GSH-Px activity remained
constant from GD 9 (25.8± 2.75 nmol NADPH ox-
idized/min/mg protein) to GD 10 (17.4± 1.23 nmol
NADPH oxidized/min/mg protein), but then increased
significantly on GD 11 by 240% (59.2± 3.19 nmol
NADPH oxidized/min/mg protein) from GD 10. This
trend continued where GSH-Px activity increased by
35% from GD 11 to GD 12 (79.7± 3.61 nmol NADPH
oxidized/min/mg protein) and by 21% from GD 12
to GD 13 (96.2± 0.76 nmol NADPH oxidized/min/mg
protein).
Regional measurements of GSH-Px activity dur-
ing early development showed relatively low GSH-Px
FIGURE 1. Glutathione peroxidase specific activity in early gesta-
tion. Embryos were removed and sorted by somite number (0–12
[n= 7], 13–20 [n= 7], 21–28 [n= 11], 29+ [n= 11]) indicating GD 9–
12, respectively, after which both embryo (solid line) and VYS (dotted
line) enzyme activity were determined. GSH-Px Specific activities are
expressed as nmol NADPH oxidized/min/mg protein. Data are rep-
resented as means± SEM.
activities in the head, heart, and trunk, ranging from
3.1± 0.67 nmol NADPH oxidized/min/mg protein
(head) to 5.8± 0.1.02 nmol NADPH oxidized/min/mg
protein (heart; Figure 2). No significant changes in
GSH-Px activity was seen on GD 10, but significant
increases in GSH-Px activity were detected on GD 11
in all tissues, increasing 8-fold in the head, 4.6-fold
in the trunk, and 2.2-fold in the heart. While GSH-Px
activities in the head (28.3± 1.46 nmol NADPH ox-
idized/min/mg protein) and trunk (33.7± 3.24 nmol
NADPH oxidized/min/mg protein) remained rela-
tively constant on GD 12, the heart GSH-Px activity in-
creased to 38.2± 5.17 nmol NADPH oxidized/min/mg
protein, an increase of 172% from that on GD 11. GD 13
GSH-Px activities in the head and trunk did not change
significantly, but the heart GSH-Px increased by 19% to
45.4± 1.01 nmol NADPH oxidized/min/mg protein.
FIGURE 2. Glutathione peroxidase specific activity in head (dotted
line diamond), trunk (open squares), and heart (open triangles) from
embryos sorted by somite number (0–12 [n= 8], 13–20 [n= 9], 21–
28 [n= 17], 29+ [n= 11]) indicating GD 9–12, respectively. GSH-Px
specific activities are expressed as nmol NADPH oxidized/min/mg
protein. Data are represented as means± SEM.
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Glutathione Disulfide Reductase
The GD 9 embryo contained very little GSSG-Rd
activity (12.3± 0.74 nmol NADPH oxidized/min/mg
protein) as compared to the GD 9 VYS (36.4± 4.06 nmol
NADPH oxidized/min/mg protein, Figure 3). Embry-
onic GSSG-Rd activity on GD 10 did not change sig-
nificantly (10.1± 0.69 nmol NADPH oxidized/min/mg
protein) but GSSG-Rd activity increased in the VYS
by 40% to 51.0± 2.21 nmol NADPH oxidized/min/mg
protein. Embryonic GSSG-Rd activity increased sig-
nificantly on the following day (GD 11) by 158%
to 26.5± 1.72 nmol NADPH oxidized/min/mg pro-
tein, but did not increase further on the following
2 days of development (GD 12: 26.0± 1.87 and GD 13:
29.2± 0.65 nmol NADPH oxidized/min/mg protein).
While VYS GSSG-Rd activity increased to 63.0±
3.50 nmol NADPH oxidized/min/mg protein, an in-
crease of 24% from GD 11, the greatest increase
was detected on GD 12 where VYS GSSG-Rd activity
increased by 126% to 124.4± 8.02 nmol NADPH
oxidized/min/mg protein. VYS GSSG-Rd increased
even further on GD 13 to 180.3± 6.26 nmol NADPH
oxidized/min/mg protein, an increase of 27%.
On GD 9, head (3.8± 0.45 nmol NADPH ox-
idized/min/mg protein) and heart (4.2± 0.46 nmol
NADPH oxidized/min/mg protein) GSSG-Rd activ-
ities were not statistically different, but the GSSG-
Rd activity of the trunk (7.5± 0.63 nmol NADPH
oxidized/min/mg protein) showed was significantly
more, 97 and 78% of the head and heart, respec-
tively (Figure 4). GSSG-Rd activities in the head (4.4±
0.52 nmol NADPH oxidized/min/mg protein) and
trunk (8.0± 0.49 nmol NADPH oxidized/min/mg pro-
tein) remained constant on GD 10 but increased signif-
FIGURE 3. Glutathione disulfide reductase specific activity in early
gestation. Embryos were removed and sorted by somite number (0–12
[n= 6], 13–20 [n= 8], 21–28 [n= 13], 29+ [n= 9]) indicating GD 9–12,
respectively, after which both embryo (solid line) and VYS (dotted
line) enzyme activity were determined. GSSG-Rd specific activities
are expressed as nmol NADPH oxidized/min/mg protein. Data are
represented as means± SEM.
FIGURE 4. Glutathione disulfide reductase specific in head (dotted
line diamond), trunk (open squares), and heart (open triangles) from
embryos sorted by somite number (0–12 [n= 7], 13–20 [n= 11], 21–
28 [n= 14], 29+ [n= 14]) indicating GD 9–12, respectively. GSSG-Rd
specific activities are expressed as nmol NADPH oxidized/min/mg
protein. Data are represented as means± SEM.
icantly in heart to 7.9± 1.03 nmol NADPH oxidized/
min/mg protein, an increase of 88%. The greatest
increases in GSSG-Rd activity was detected on GD
11. The head showed the greatest increase (6.5-fold)
to 28.4± 2.33 nmol NADPH oxidized/min/mg pro-
tein and was followed by that in the trunk (3.9-fold)
to 31.5± 1.20 nmol NADPH oxidized/min/mg pro-
tein. The heart increased by 3.3-fold to 26.1± 2.94
nmol NADPH oxidized/min/mg protein. GSSG-Rd
activities for the head and trunk did not signifi-
cantly change on either GD 12 or GD 13. However,
the heart increased on both GD 12 (34.0± 1.17 nmol
NADPH oxidized/min/mg protein) by 30% and GD 13
(44.9± 2.11 nmol NADPH oxidized/min/mg protein)
by 32%.
Superoxide Dismutase
Since this is an inhibition assay, lower SOD
measurements reflect a greater SOD activity. Early
organogenesis-staged (GD 9) embryos had relatively
low levels of SOD, 9.6± 0.54 units SOD/mg pro-
tein (Figure 5). As development progressed, embry-
onic SOD activity increased, 7.9± 0.20, 3.6± 0.14, and
3.3± 0.18 units SOD/mg protein for somite ranges
2 through 4 on GD 10, 11, and 12, respectively. The
VYS during this same period (GD 9–12) also showed
SOD activity changes. The least amount of SOD ac-
tivity in the VYS was noted at GD 9, 11.2± 1.57 units
SOD/mg protein (Figure 5), but SOD increased every
subsequent day, 9.2± 0.60 (GD 10), 4.6± 0.19 (GD 11),
and 4.0± 0.17 (GD 12) units SOD/mg protein. No sig-
nificant differences were detected between the embryo
and VYS on GD 9, but statistically significant differ-
ences between the embryo and VYS were detected on
each of the succeeding days, GD 10–GD 12.
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FIGURE 5. Superoxide dismutase specific activity in early gesta-
tion. Conceptus were removed and sorted by somite number (0–12
[n= 8], 13–20 [n= 8], 21–28 [n= 10], 29+ [n= 9]) indicating GD 9–12,
respectively, after which both embryo (solid line) and VYS (dotted
line) enzyme activity were determined. One unit of SOD activity is
the amount of enzyme producing a 50% inhibition of the conver-
sion of epinephrine to adrenochrome. Specific activities are expressed
as units of activity per milligram protein. Data are represented as
means± SEM.
Closer inspection of SOD activities in regions of the
embryo on GD 9 showed that the head, trunk, and heart
all have relatively equal SOD activity (head: 5.4± 0.70;
trunk: 5.5± 0.08; heart: 4.0± 1.57 units SOD/mg pro-
tein; Figure 6). However, statistically significant dif-
ferences were detected on the following day (GD 10),
where the trunk and heart showed 23% (5.5± 0.24 units
SOD/mg protein) and 35% (4.6± 0.49 units SOD/mg
protein) more SOD activity, respectively, than that in the
head (7.1± 0.28 units SOD/mg protein). This trend re-
versed itself in the heart, and SOD activity decreased on
GD 11 by 55% (7.1± 0.68 units SOD/mg protein), which
was statistically different from the head (3.3± 0.41 units
SOD/mg protein) and trunk (2.3± 0.14 units SOD/mg
FIGURE 6. Superoxide dismutase specific activity in head (dotted
line diamond), trunk (open squares), and heart (open triangles) from
embryos sorted by somite number (0–12 [n= 7], 13–20 [n= 9], 21–28
[n= 11], 29+ [n= 10]) indicating GD 9–12, respectively. One unit of
SOD activity is the amount of enzyme producing a 50% inhibition
of the conversion of epinephrine to adrenochrome. Specific activities
are expressed as units of activity per milligram protein. Data are
represented as means± SEM.
protein) SOD activities on GD 11, which both increased
from the preceding day. Head and trunk continued
to increase on GD 12 and measured 2.0± 0.05 and
1.7± 0.04 units SOD/mg protein and were statistically
different from the SOD activity of the heart (6.8± 0.36
units SOD/mg protein).
Enzyme Activities: Late Organogenesis
(GD 14–21)
Glutathione Peroxidase
Glutathione peroxidase activities of most embry-
onic tissues did not change during development from
GD 14 to GD 21. Rat brain, lung, placenta, and heart
GSH-Px activity fluctuated but basically remained con-
stant where changes were not statistically significant
(brain: increased 2%; lung: increased by 37%; pla-
centa: increased by 28%; heart: decreased by 30%; Fig-
ure 7). Tissues that did change significantly during
this period were the liver (GD 14: 31.4± 1.71 nmol
NADPH oxidized/min/mg protein) and the kidney
(GD 16: 28.4± 2.25 nmol NADPH oxidized/min/mg
protein), measuring increases in GSH-Px activity by
92% and 160% (from GD 14–16 to GD 21), respec-
tively. Interestingly, the kidney did not show any sig-
nificant changes until the day just prior to birth, nearly
doubling from GD 20 (33.9± 1.76 nmol NADPH ox-
idized/min/mg protein) to GD 21 (73.8± 3.50 nmol
NADPH oxidized/min/mg protein). The VYS was the
FIGURE 7. Ontogeny of glutathione peroxidase specific activity in
late gestation (GD 14 [n= 7], 16 [n= 7], 18 [n= 11], 20 [n= 9] and 21
[n= 9]) of the embryonic heart, brain, liver, lung, kidney, VYS, and
placenta. GSH-Px specific activities are expressed as nmol NADPH
oxidized/min/mg protein. Data are represented as means± SEM.
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single tissue that showed constitutively high levels of
GSH-Px activity and was statistically different from
most other tissues on GD 14 (68.2± 2.73 nmol NADPH
oxidized/min/mg protein) but did not increase signif-
icantly during later phases of development, only in-
creasing slightly by 12% (76.5± 3.57 nmol NADPH
oxidized/min/mg protein).
Glutathione Disulfide Reductase
On GD 14, only one tissue showed considerably
higher levels of GSH-Px activity as compared to other
tissues and organs, the VYS (Figure 8). The GD 14 VYS
showed 172.1± 9.91 nmol NADPH oxidized/min/mg
protein, 207% higher than the next highest tissue,
the liver (56.0± 1.94 nmol NADPH oxidized/min/mg
protein). The brain, liver, kidney, and lung all in-
creased during this period of development (GD 14–21),
ranging from larger increases of 86% (liver: GD 14:
56.0± 1.94 nmol NADPH oxidized/min/mg protein;
GD 21: 105.6± 6.70 nmol NADPH oxidized/min/mg
protein) to smaller increases of 16% (kidney: GD 16:
55.7± 3.61 nmol NADPH oxidized/min/mg protein;
GD 21: 64.7± 6.06 nmol NADPH oxidized/min/mg
protein). No significant changes were detected in heart
or the placenta during this time. The only tissue shown
to considerably decrease over this period was the VYS,
dropping from GD 14 (172.1± 9.91 nmol NADPH ox-
idized/min/mg protein) to GD 21 (93.8± 6.15 nmol
NADPH oxidized/min/mg protein) by 45%.
FIGURE 8. Ontogeny of glutathione disulfide reductase specific
activity in late gestation (GD 14 [n= 8], 16 [n= 7], 18 [n= 11],
20 [n= 10] and 21 [n= 8]) of the embryonic heart, brain, liver, lung,
kidney, VYS, and placenta. GSSG-Rd specific activities are expressed
as nmol NADPH oxidized/min/mg protein. Data are represented as
means± SEM.
DISCUSSION
Intracellular redox gradients are believed to play an
important role in cellular growth regulation and mat-
uration of cellular function. Metabolically generated
oxidants and cellular antioxidant status have been im-
plicated as important factors that direct the initiation
of developmental events such as differentiation and
proliferation (22–24, 34–36). Because several teratogens
are capable of producing oxidative stress and subse-
quent changes in redox status, the delayed or preco-
cious appearance of antioxidant enzymes such as SOD,
GSH-Px, and GSSG-Rd in specific cell types may thus
contribute to developmental regulation as well as the
differential sensitivity to teratogens and developmen-
tal toxicants. The metabolic generation of ROS from
dioxygen (HO•, O •−2 and H2O2) require the sequential
action of SOD, GSH-Px, and GSSG-Rd for the efficient
removal and protection from the potentially damaging
oxygen intermediates. The primary aim of the studies
described in this report is to evaluate developmental
enzyme ontogenies and the relationships between
GSH-dependent antioxidant enzymes, GSH-Px and
GSSG-Rd. An overall assessment of how the capacity to
maintain GSH status and overall redox homeostasis is
altered by teratogens will require an understanding of
the cellular environments in which these changes take
place. Although not directly related to GSH status, a
comparison of SOD activities was also included with
the early embryonic stages because it was of interest to
determine whether changes in GSH-Px activities were
correlated with activities of the major enzyme respon-
sible for the generation of its substrate, H2O2.
During the early developmental periods (GD 9–13),
we demonstrated that embryonic GSH-Px and GSSG-
Rd activities did not change significantly in the em-
bryo proper, but increase several fold in the VYS. This
suggests that the cells of the embryo may not be pro-
grammed to respond to the dramatic alterations in oxy-
gen availability and metabolic activity that occurs (GD
10–11) as the heart and vascular systems become func-
tional and the conceptus converts from predominantly
anaerobic glycolysis to the citric acid cycle (CAC) and
mature mitochondrial functions.
The rodent VYS completely surrounds the develop-
ing embryo at this stage of development and has been
shown to have considerable metabolic activity as well
as capacities for bioactivation and detoxication [15,37].
We have reported that GSH oxidation and GSH-protein
mixed disulfide production following xenobiotic insult
are consistently greater in the VYS compared with the
embryo proper so that the more dramatic increases for
GSH-Px and GSSG-Rd over developmental time may
reflect the special protective role of the VYS in terms of
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removal of ROS [38]. It is also of interest that the largest
increment of increase for GSH-Px activity occurs dur-
ing a 24-h interval corresponding to the transition from
glycolysis to CAC activity and the onset of active circu-
lation. We still do not understand the biochemical and
molecular mechanisms that might combine to regulate
increased expression of these enzymes, not the mecha-
nisms that regulate their appearance and activities.
Superoxide dismutase activities continue to in-
crease over the early developmental times (GD 9–12)
and are not different between the embryo and VYS,
nor do they appear to respond to the aforementioned
shift in metabolic activity occurring between GD 10 and
GD 11. In the embryo, SOD activities plateau and coin-
cide with significant increases in GSH-Px after GD 12.
Unlike GSH-Px and GSSG-Rd, SOD activities are not
dependent on intermediary metabolism and the pro-
duction of cofactors such as GSH and NADPH, making
it possible for existing SOD activities to adequately con-
vert ever increasing superoxide concentrations to H2O2
without a regulated increase in expression. The tempo-
ral patterns of change and relative differences in activity
between tissues we report are in agreement with previ-
ously published ontogenies [39–41].
In order to understand whether the cell and
tissue specific differences in antioxidant enzyme activ-
ities that exist in the embryo could help explain dif-
ferential sensitivity to teratogens, we began by com-
paring different tissue segments within the embryo
proper. Because removal and assay of specific organs
was not practical or possible during the early phases
of development, only heads, trunks, and hearts were
compared. Relatively few differences in GSH-Px and
GSSG-Rd activities were observed between the three
tissue segments, again indicating the apparent indiffer-
ence of the embryo proper in responding to metabolic
and environmental changes. Significant increases of ac-
tivity for both enzymes in the heart on GD 13 are the
first signs of selective cell regulation in the embryo. Co-
incidentally, SOD activities show the opposite reaction
in the heart, where activities decline with advancing
gestation age. It could be argued that a functional pla-
centa (GD 13) and maturation of SOD activity in other
tissues are reducing the commitment of the heart for its
own antioxidant protection.
As organs mature and sufficient quantities of tis-
sue are available to facilitate accurate assays (GD 14–
21), we were able to determine antioxidant enzyme ac-
tivities in hearts, brains, liver, lung, kidney, VYS, and
placenta during the fetal period. Our expectations were
that, as organs mature and prepare for the transition to
extra-uterine live they will begin to differentially ex-
press antioxidant enzymes, resulting in the increase of
activities to levels necessary to protect cells from in-
herent metabolism-dependent ROS formation. In the
process, these mature organs will assume a responsi-
bility for the detoxication of ROS initially maintained
by the VYS but which is lost with the shedding of the
VYS. Nevertheless, until parturition occurs the rat VYS
continues to maintain the highest GSH-Px and GSSG-
Rd activities. The heart, lung, placenta, and brain show
relatively minor changes in activity from GD 14 un-
til term. A study of SOD and GSH-Px expression in
mice confirms that these organs show relatively minor
changes during the latter half of gestation but demon-
strate the dramatic increases that can occur following
parturition [39]. The most significant increases in activ-
ity occurring during the latter half of gestation appear in
the kidney and liver for GSH-Px. A gradual increase in
GSH-Px specific activity is observed in the liver during
the latter half of the gestation period and is contrasted
by a rapid rise of activity in the kidney just prior to
parturition at GD 20. Mature kidney and liver both con-
tain the metabolic capacity to produce large amounts of
ROS but also develop the capacity to remove it. We are
not surprised that activities increase just prior to term
when the VYS and other maternal support systems are
no longer available to afford protection to the neonate.
Based on the data provided in this report it is un-
wise to interpret the results in terms of developmental
regulation and the related teratogenic responses with
out consideration of the various dynamic changes re-
lating to all of the regulatory pathways involved. The
innate ability of cells to respond to oxidative stress
and restore redox homeostasis is of considerable
importance in terms of regulation and cellular protec-
tion. Following insult, responses may involve the in-
creased availability of the cofactors GSH and NADPH
or may include increased availability of the enzymes
themselves. Amicarelli et al. [41] have shown recently
that exposure of mouse conceptuses in whole embryo
culture to the teratogen phenytoin results in signifi-
cant alteration in antioxidant activities of GD 14 and
GD 19. Phenytoin was shown to significantly increase
GSSG-Rd and GSH-Px activities in the GD 14 fetal liver,
but were conversely shown to significantly decrease the
same activities on GD 19. These results suggest that care
be taken not to assume that all responses of a given tis-
sue remain the same over any developmental period.
It is not known at this time whether teratogen-induced
changes in the intracellular redox status is, in any way,
directly related to the cellular modulation of antioxi-
dant enzyme activity. This will remain an open question
for further study.
The establishment of enzyme ontogeny profiles
is only an approximation to the understanding of
differences in organ function and their regulation
development. They do, however, provide a more fun-
damental knowledge regarding the potential relation-
ships between different organs and tissues in terms of
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their relative protective capacitates and reasons why
embryonic cells have such different responses to chem-
ical embryotoxicants and teratogens. Disturbances in
the intracellular redox balance have been shown to play
a major part in the control and regulation of normal
developmental events such as proliferation and differ-
entiation [22–24,38,42]. The capacity of cells and tis-
sues to respond to chemical and environmental stresses
and restore normal redox homeostasis may determine
whether cells continue in a normal course of develop-
ment or succumb to various stages of toxicity that could
result in malformation, functional alterations, or death.
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